September 8 Weekly Round-Up: NEC Members Contribute to COVID-19 Crisis Response

As our region and our nation continue to grapple with the Coronavirus Disease (COVID-19) pandemic, The New England Council is using our blog as a platform to highlight some of the incredible work our members have undertaken to respond to the outbreak. Once a week, we’ll post a round-up of updates on some of the initiatives underway among Council members throughout the region.  We are also sharing these updates via our social media, and encourage our members to share with us any information on their efforts so that we can be sure to include them in these weekly round-ups.

You can find all the Council’s information and resources related to the crisis in the special COVID-19 section of our website.  This includes our COVID-19 Virtual Events Calendar, which provides information on upcoming COVID-19 Congressional town halls and webinars presented by NEC members, as well as our Federal Agency COVID-19 Guidance for Businesses page.

Here is today’s (September 8, 2020) roundup:

Medical Response

  • Beth Israel COVID-19 Vaccine Candidate Prevents Severe Clinical Disease in Animals – Researchers at Beth Israel Deaconess Medical Center got encouraging results in preventing high viral loads in animals, in trials for a Covid-19 Vaccine. Pending trial outcomes, the vaccine candidate is on track to start phase three of testing, involving thousands of participants. Read more here.
  • MilliporeSigma Supports Eijkman Institute to Expedite Covid-19 Vaccine Development Research MilliporeSigma recently announced that the company will donate over $85,000 worth of research instruments and materials to support the Eijkman Institute for Molecular Biology, which is concentrated on developing a vaccine for a local COVID-19 strain. Read more here.
  • FDA Issues Emergency Use Authorization for ABIOMED Impella Heart Pump to Treat COVID-19 PatientsABIOMED’s Impella Heart Pump was granted an emergency use authorization after the pump was able to support heart function for COVID-19 positive patients with severe cases. The pump was integral to the survival and recovery of a severely ill patient. Read more here.

Community Response

  • Harvard-MIT Center for Regulatory Science Organizes Greater Boston Pandemic Fabrication Team – In order to address the PPE shortage caused by the pandemic, experts from Harvard Medical School and the Massachusetts Institute of Technology organized 150 of their colleagues into the Greater Boston Pandemic Fabrication Team (PanFab). PanFab has designed multiple innovative solutions to PPE shortages, including a redesigned face shield. Read more here.

Stay tuned for more updates each day, and follow us on Twitter for more frequent updates on how Council members are contributing to the response to this global health crisis.








Recently from the Blog

Vertex Releases Findings in Type 1 Diabetes Trial

11/9/2021 | Read Post

Amazon will be Hiring 1,500 Seasonal Workers

11/9/2021 | Read Post

In the News

NEC to Honor Historic All-Female Lineup of 2021 New Englanders of the Year

08/2/2021 | Read Press Release

NEC Board Elects Three New Directors

04/27/2021 | Read Press Release